Sync-Rx develops automated online image processing for trans-catheter cardiovascular interventions.
Medical imaging solutions developer Sync-Rx Ltd. has been acquired by US medical devices company Volcano Corporation (Nasdaq: VOLC) for $17.3 million. Sync-Rx, jointly owned by Rafael Advanced Defense Systems Ltd. and Elron Electronic Industries Ltd. (TASE: ELRN) through their joint venture Rafael Development Corporation (RDC), develops automated online image processing to optimize and facilitate trans-catheter cardiovascular interventions.
Netanya-based Sync-Rx was founded in 2007. It will become a wholly-owned subsidiary of San Diego-based Volcano. Sync-Rx currently focuses on coronary catheterizations, and it plans to develop applications for structural heart disease. Volcano said that it plans to expand Sync-Rx's technology to work with real-time intra-body physiology measurements and intravascular ultrasound, intra-cardiac echocardiography, and optical coherence tomography imaging.